News

Alzheimer’s disease is the most common type of dementia that progressively deteriorates a person’s memory, cognition, and behavior, until accomplishing activities of daily living (ADLs) becomes difficult. Despite decades of intensive research, no one has yet to find a cure for Alzheimer’s. What are currently available are medications…

Playing certain types of computer games can be an effective alternative for treating elderly people diagnosed with depression whose symptoms exhibit resistance to conventional treatments, a new study showed. The study, titled “Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression” and published in the journal…

Although obese individuals are at a 35% higher risk for Alzheimer’s disease than healthy-weight individuals, it might be possible to reduce the risk by losing weight through bariatric surgery. “Changes in Brain After Bariactric Surgery,” published in Journal of Clinical Endocrinology & Metabolism…

Scientists from the VIB Center for the Biology of Disease, KU Leuven identified the molecules responsible for the neurodegenerative process in the human brain by analyzing the nerve tissue of zebrafish embryos, a study that is expected to advance knowledge about the regulation of stem cells and further insights into Alzheimer’s…

The Alzheimer’s Prevention Registry recently enrolled the 40,000th volunteer to take part in a major study on Alzheimer’s disease that will be conducted by Banner Alzheimer’s Institute (BAI) in collaboration with other organizations and scientists. The online gateway’s main purpose is to accelerate research by connecting healthy people who are committed to…

Even though Alzheimer’s disease is typically only diagnosed in the elderly population, the disease is already present in the brain long before symptoms become visible. Researchers at University of Stanford believe they have found a few promising signs that indicate the early presence of the disease in patients as a result of observing the development…

A research team from the University of Exeter Medical School and King’s College London has uncovered strong evidence of neurological epigenetic changes leading to Alzheimer Disease (AD) development. There are over 26 million people affected by AD worldwide, a chronic neurodegenerative disorder characterized by progressive neuropathology and cognitive decline. Despite…

Almost two-thirds of more than five million Americans currently living with Alzheimer’s disease (AD) are women, and American women are twice as likely to die of Alzheimer’s disease as they are from breast cancer. According to the Alzheimer’s Association, someone in America develops Alzheimer’s every 67 seconds, and in…

A new study by researchers at the Stanford University School of Medicine has found that some constituent or agent in the blood of young mice when infused to the bloodsteams of old mice has the ability to restore deteriorating mental capabilities. The scientists suggest that if the same phenomenon…

An intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer’s disease has been successfully performed by Stemedica International, a subsidiary of Stemedica Cell Technologies, developing stem cell therapies for Alzheimer’s disease and dementia. The first results of the…